[Hospital spread of scabies from an immunocompromised patient with Norwegian scabies]. 1991

H Iwasaki, and T Fukushima, and M Uchida, and T Ueda, and T Nakamura, and K Ishiguro, and K Ueda, and N Takada
First Department of Internal Medicine, Fukui Medical School, Japan.

Scabies was first found in a 71-year-old female who had been diagnosed as having leukemic transformation of primary myelofibrosis and had undergone treatment for the disease. She was admitted to the hospital in December 1986, because of abdominal fullness and a generalized subcutaneous tumor that proved to be myeloblastoma. For treatment of the underlying disease, the regimen of the combination of vindesine, cyclophosphamide, 6-mercaptopurine, and prednisolone was selected. She developed cardiac failure and fell into a coma one month after starting the anticancer therapy. She was put on artificial respiration and on additional steroid therapy as well. Dexamethasone was administrated at 16 mg/day. Since the myeloblastomas found on admission regressed, the steroid therapy was continued. She was in coma for a few days before her skin lesions turned red and formed a grayish crust in the lower abdominal region. Several days later, the doctor responsible for the treatment of this patient developed pruritus and exanthema on both arms, and soon many nurses in the same hospital-ward developed similar symptoms. At approximately the same time, the patient with myelofibrosis was diagnosed as having Norwegian scabies: the crusted skin lesions revealing many Sarcoptes scabiei mites. Two doctors (2/18), 17 nurses (17/19) and 3 other patients (3/51) were found to have contracted scabies, and we recognized the hospital spread of the infection. The first patient was isolated in a private room, and we avoided direct contact with her. The persons with scabies were treated with crotamiton liniment. The first scabies patient died of cardiac failure 1 month after falling into a coma.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D009894 Opportunistic Infections An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression. Infection, Opportunistic,Infections, Opportunistic,Opportunistic Infection
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012532 Scabies A contagious cutaneous inflammation caused by the bite of the mite SARCOPTES SCABIEI. It is characterized by pruritic papular eruptions and burrows and affects primarily the axillae, elbows, wrists, and genitalia, although it can spread to cover the entire body. Mange, Sarcoptic,Sarcoptic Mange
D016867 Immunocompromised Host A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation. Immunosuppressed Host,Immunocompromised Patient,Host, Immunocompromised,Host, Immunosuppressed,Hosts, Immunocompromised,Hosts, Immunosuppressed,Immunocompromised Hosts,Immunocompromised Patients,Immunosuppressed Hosts,Patient, Immunocompromised,Patients, Immunocompromised

Related Publications

H Iwasaki, and T Fukushima, and M Uchida, and T Ueda, and T Nakamura, and K Ishiguro, and K Ueda, and N Takada
January 2004, Journal of the American Podiatric Medical Association,
H Iwasaki, and T Fukushima, and M Uchida, and T Ueda, and T Nakamura, and K Ishiguro, and K Ueda, and N Takada
May 1990, Lancet (London, England),
H Iwasaki, and T Fukushima, and M Uchida, and T Ueda, and T Nakamura, and K Ishiguro, and K Ueda, and N Takada
May 1990, International journal of STD & AIDS,
H Iwasaki, and T Fukushima, and M Uchida, and T Ueda, and T Nakamura, and K Ishiguro, and K Ueda, and N Takada
December 1996, Enfermedades infecciosas y microbiologia clinica,
H Iwasaki, and T Fukushima, and M Uchida, and T Ueda, and T Nakamura, and K Ishiguro, and K Ueda, and N Takada
January 1960, Bulletin de la Societe francaise de dermatologie et de syphiligraphie,
H Iwasaki, and T Fukushima, and M Uchida, and T Ueda, and T Nakamura, and K Ishiguro, and K Ueda, and N Takada
February 2004, Sexually transmitted infections,
H Iwasaki, and T Fukushima, and M Uchida, and T Ueda, and T Nakamura, and K Ishiguro, and K Ueda, and N Takada
January 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
H Iwasaki, and T Fukushima, and M Uchida, and T Ueda, and T Nakamura, and K Ishiguro, and K Ueda, and N Takada
June 1995, Genitourinary medicine,
H Iwasaki, and T Fukushima, and M Uchida, and T Ueda, and T Nakamura, and K Ishiguro, and K Ueda, and N Takada
January 1985, Dermatologica,
H Iwasaki, and T Fukushima, and M Uchida, and T Ueda, and T Nakamura, and K Ishiguro, and K Ueda, and N Takada
January 2022, Dermatitis : contact, atopic, occupational, drug,
Copied contents to your clipboard!